by Dianne Scheinberg, MS, RD, LDN
The thyroid is a gland in the lower neck. It makes hormones that regulate growth, brain development, and metabolism. Hypothyroidism is a low or absent production of these hormones. Congenital means the condition is present since birth.
If this condition is not treated it can cause damage to the brain. This can lead to intellectual disability and abnormal growth.
In most cases, the cause is unknown, but it is probably genetic. The most common known causes are abnormal development of the thyroid gland or a defect in producing thyroid hormone. About 15% of cases are inherited.
Babies may have a temporary shortage in their thyroid hormones. This is more common in babies born before 40 weeks.
Factors that may increase the chance of congenital hypothyroidism include:
Symptoms or signs take time to develop. The symptoms of congenital hypothyroidism may include the following:
At birth, most infants are screened for this condition. Blood tests will be able to identify thyroid levels. Images of the thyroid may also be taken with:
The outcome is best if the condition is caught early. It is important to start treatment before the brain and nervous system are fully developed. If treatment is given early, it can prevent damage. Left untreated, the condition will lead to poor mental development and delayed growth.
Medication will treat the hypothyroidism. The medication will replace the missing hormone.
Once medication starts, the levels of thyroid hormones are checked often. This will help to keep the values within a normal range. If values are kept within a normal range, there are no side effects or complications.
Most cases cannot be prevented. The following are some things the mother can do during pregnancy to reduce the risk:
American Thyroid Association
Genetics Home Reference
Thyroid Foundation of Canada
American Academy of Pediatrics, Rose SR, Section on Endocrinology and Committee on Genetics, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics. 2006;117(6):2290-2303.
Bongers-Schokking JJ, Koot HM, et al. Influence of timing and dose of thyroid hormone replacement on the development in infants with congenital hypothyroidism. J Ped. 2000;136(3):292-297.
Castanet M, Polak M, Leger J. Familial forms of thyroid dysgenesis. Endocr Dev. 2007;10:15-28.
Gruters A, Krude H, Biebermann H. Molecular genetic defects in congenital hypothyroidism. Europ J Endocr. 2004;151 Suppl 3:U39-U44.
Congenital hypothyroidism. EBSCO DynaMed Plus website. Available at: http://www.dynamed... . Updated March 24, 2016. Accessed November 28, 2017.
LeFranchi SH, Austin J. How should we be treating children with congenital hypothyroidism. J Pediatr Endocrinol Metab. 2007;20(5):559-578.
Last reviewed November 2018 by EBSCO Medical Review Board James Cornell, MD
Last Updated: 12/20/2014
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at email@example.com. Our Health Library Support team will respond to your email request within 2 business days.